Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events
PaperCitations, authors & open-access status
Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 7 citations, 2018 year and gold oa status.
7
Citations
2018
Year
gold
OA Status